Literature DB >> 25206293

Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study.

Ping Xu1, Cheng-Fu Xu1, Xing-Yong Wan1, Chao-Hui Yu1, Chao Shen1, Peng Chen1, Gen-Yun Xu1, You-Ming Li1.   

Abstract

AIM: To investigate the association between serum alpha-fetoprotein (AFP) levels and fatty liver disease (FLD) in a Chinese population.
METHODS: A cross-sectional study was performed among subjects who presented for a health examination at the First Affiliated Hospital, College of Medicine, Zhejiang University in 2013. FLD was diagnosed based on an ultrasonography examination. Serum AFP levels were measured with a chemiluminescence immunoassay.
RESULTS: Of the 9800 subjects enrolled, 2601 were diagnosed with FLD. Subjects with FLD had higher serum AFP levels than those without the disease. Subjects with high serum AFP levels had a higher prevalence of FLD, metabolic syndrome, and its components. Univariate logistic analysis showed that elevated serum AFP levels were associated with an increased risk of FLD (OR = 1.057, 95%CI: 1.031-1.084). However, after adjusting for covariates, AFP no longer remained significantly associated with the risk factors for FLD.
CONCLUSION: Our results suggest that serum AFP levels are significantly associated with FLD and that AFP acts as a cofactor, but not as an independent factor, for FLD.

Entities:  

Keywords:  Alpha-fetoprotein; Association; Fatty liver; Obesity; Risk factor

Mesh:

Substances:

Year:  2014        PMID: 25206293      PMCID: PMC4155379          DOI: 10.3748/wjg.v20.i33.11865

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.

Authors:  Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Pavel Vladimirovich Korita; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

3.  Serum alpha-fetoprotein in patients with nonalcoholic fatty liver disease.

Authors:  S A Polyzos; J Kountouras
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-09       Impact factor: 3.507

Review 4.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

5.  Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases.

Authors:  Min De Zeng; Jian Gao Fan; Lun Gen Lu; You Ming Li; Cheng Wei Chen; Bing Yuan Wang; Yi Min Mao
Journal:  J Dig Dis       Date:  2008-05       Impact factor: 2.325

6.  Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.

Authors:  Chengfu Xu; Chaohui Yu; Han Ma; Lei Xu; Min Miao; Youming Li
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

Review 7.  Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.

Authors:  Katsutoshi Tokushige; Etsuko Hashimoto; Kazuhiko Kodama
Journal:  J Gastroenterol Hepatol       Date:  2013-12       Impact factor: 4.029

8.  Nonalcoholic fatty liver disease in Asia: a story of growth.

Authors:  Vincent Wai-Sun Wong
Journal:  J Gastroenterol Hepatol       Date:  2013-01       Impact factor: 4.029

9.  Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.

Authors:  Paulo S Ribeiro; Helena Cortez-Pinto; Susana Solá; Rui E Castro; Rita M Ramalho; Amélia Baptista; Miguel C Moura; Maria E Camilo; Cecília M P Rodrigues
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

10.  Serum α-fetoprotein levels in liver steatosis.

Authors:  Ayşegül Babalı; Erman Cakal; Tuğrul Purnak; Ibrahim Bıyıkoğlu; Başak Cakal; Osman Yüksel; Seyfettin Köklü
Journal:  Hepatol Int       Date:  2009-11-05       Impact factor: 6.047

View more
  14 in total

1.  Liver-function parameters are associated with incident hypertension in a large Taiwanese population follow-up study.

Authors:  Yi-Hsueh Liu; Szu-Chia Chen; Wen-Hsien Lee; Ying-Chih Chen; Jiun-Chi Huang; Pei-Yu Wu; Chih-Hsing Hung; Chao-Hung Kuo; Ho-Ming Su
Journal:  J Hum Hypertens       Date:  2022-05-26       Impact factor: 3.012

2.  Association between circulating cystatin C and hyperuricemia: a cross-sectional study.

Authors:  Yanjun Guo; Hangkai Huang; Yishu Chen; Chao Shen; Chengfu Xu
Journal:  Clin Rheumatol       Date:  2022-03-31       Impact factor: 2.980

3.  Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study.

Authors:  Jin-Zhou Zhu; Hua-Tuo Zhu; Yi-Ning Dai; Chun-Xiao Li; Zhi-Yun Fang; De-Jian Zhao; Xing-Yong Wan; Yu-Ming Wang; Fang Wang; Chao-Hui Yu; You-Ming Li
Journal:  Endocrine       Date:  2015-09-11       Impact factor: 3.633

4.  Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.

Authors:  Kelvin Nguyen; Melissa Jimenez; Nima Moghadam; Crystal Wu; Alex Farid; Jonathan Grotts; David Elashoff; Gina Choi; Francisco A Durazo; Mohamed M El-Kabany; Steven-Huy B Han; Sammy Saab
Journal:  J Clin Transl Hepatol       Date:  2017-03-08

5.  Proteomic Analysis of Fetal Ovary Reveals That Ovarian Developmental Potential Is Greater in Meishan Pigs than in Yorkshire Pigs.

Authors:  Mengmeng Xu; Long Che; Dingyue Wang; Zhenguo Yang; Pan Zhang; Yan Lin; Zhengfeng Fang; Lianqiang Che; Jian Li; Daiwen Chen; De Wu; Shengyu Xu
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

6.  Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.

Authors:  Yimin Chen; Ying Zhao; Linmin Feng; Jie Zhang; Juanwen Zhang; Guofang Feng
Journal:  Lipids Health Dis       Date:  2016-04-27       Impact factor: 3.876

7.  Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study.

Authors:  Zhenya Lu; Han Ma; Chengfu Xu; Zhou Shao; Chao Cen; Youming Li
Journal:  Biomed Res Int       Date:  2016-02-10       Impact factor: 3.411

8.  Elevation of tumour markers TGF-β, M2-PK, OV-6 and AFP in hepatocellular carcinoma (HCC)-induced rats and their suppression by microalgae Chlorella vulgaris.

Authors:  Khaizurin Tajul Arifin; Suhaniza Sulaiman; Suhana Md Saad; Hanafi Ahmad Damanhuri; Wan Zurinah Wan Ngah; Yasmin Anum Mohd Yusof
Journal:  BMC Cancer       Date:  2017-12-21       Impact factor: 4.430

9.  Association study between ZFHX3 gene polymorphisms and obesity in Korean population.

Authors:  Seung-Ae Yang
Journal:  J Exerc Rehabil       Date:  2017-08-29

10.  The Association of XRCC1 Gene Polymorphisms and Chronic Hepatitis C Induced Insulin Resistance in Egyptian Patients.

Authors:  Salwa M Abo El-Khair; Mona Arafa; Tarek Besheer; Ahmed M El-Eraky; Ayman Z Elsamanoudy
Journal:  Cells       Date:  2018-10-25       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.